Portfolio company Ampa closed an oversubscribed $8.5M round and launched nationwide rollout of its FDA-cleared portable TMS brain-stimulation system.
Ampa builds scalable brain stimulation technology to eradicate despair, utilizing cutting-edge neuroscience to create practical tools for mental health treatment
Ampa builds scalable brain stimulation technology to eradicate despair, utilizing cutting-edge neuroscience to create practical tools for mental health treatment.